Phase II study of trabectedin in pretreated patients with recurrent epithelial ovarian cancer (REOC).
Marco Marinaccio
No relevant relationships to disclose
Emilia Mele
No relevant relationships to disclose
Vito Lorusso
No relevant relationships to disclose
Valeria Vincenza Fumarulo
No relevant relationships to disclose
Fausta Sozzi
No relevant relationships to disclose
Ettore Cicinelli
No relevant relationships to disclose